Stage IIIB Breast Cancer Terminated Phase 2 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01776008Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerTreatment
NCT01368263Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerTreatment